• By inhibiting PRMT3 activity, they may provide new therapeutic strategies and potential drug targets for the treatment of diseases associated with PRMT3 abnormalities, such as cardiovascular diseases and tumours. The gene discussed is PRMT3; the disease is cardiovascular disorder.